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OBJECTIVES This study evaluated the clinical, exercise stress test, and echocardiographic predictors of
mortality and cardiac events in patients with left ventricular hypertrophy (LVH).
BACKGROUND Left ventricular hypertrophy is associated with an increased risk of cardiovascular morbidity
and mortality.
METHODS Symptom-limited treadmill exercise echocardiography was performed for evaluation of
coronary artery disease in 483 patients (age, 66  11 years; 281 men) with LVH. End points
during follow-up were all-cause mortality and hard cardiac events (cardiac death and nonfatal
myocardial infarction [MI]).
RESULTS Forty-six patients died and 14 had nonfatal MI. The cumulative mortality rate was higher in
patients with abnormal exercise echocardiography (3% vs. 0.4% at one year, 11.7% vs. 3.7%
at three years, and 18.3% vs. 9.5% at five years, p  0.001). In a sequential multivariate
analysis model of clinical, exercise test, and rest and exercise echocardiographic data,
incremental predictors of mortality were workload (hazard ratio [HR], 0.5; 95% confidence
interval [CI], 0.3 to 0.9), rate pressure product (HR, 0.7; 95% CI, 0.5 to 0.9), left ventricular
(LV) mass index (HR, 1.4; 95% CI, 1.1 to 1.8), and failure to increase ejection fraction (EF)
with exercise (HR, 2.1; 95% CI, 1.1 to 3.8). Predictors of cardiac events were history of
coronary artery bypass grafting (HR, 2.6; 95% CI, 1.2 to 5.4), lower exercise rate-pressure
product (HR, 0.6; 95% CI, 0.5 to 0.8), resting wall motion score index (HR, 1.4; 95% CI,
1.1 to 1.8), and failure to increase EF with exercise (HR, 3.3; 95% CI, 1.6 to 6.9).
CONCLUSIONS In patients with LVH, LV mass index and EF response to exercise are independent predictors
of mortality, incremental to clinical and exercise test data and resting LV function. A normal
exercise echocardiogram predicts a relatively low mortality rate during the following three
years. (J Am Coll Cardiol 2003;41:129–35) © 2003 by the American College of Cardiology
Foundation
Left ventricular (LV) hypertrophy (LVH) is associated with
an increased risk of cardiovascular morbidity and mortality
(1,2). Therefore, proper evaluation of the risk status of
patients with LVH is important in order to select patients
for the appropriate interventions. Careful evaluation of
clinical data is useful in the initial risk assessment of patients
with known or suspected coronary artery disease (CAD). In
many patients noninvasive evaluation of CAD by exercise
stress testing, with the potential combination of an imaging
technique, may improve risk stratification. However, the use
of such techniques is not justified unless they provide
information incremental to what is known from clinical data
(3). Exercise electrocardiography is a widely used method
for evaluation of CAD (3–5). However, the specificity of
electrocardiographic (ECG) changes for the diagnosis of
myocardial ischemia and concomitant CAD has been re-
ported to be low in patients with LVH, even when resting
ECG abnormalities were absent (6,7). The use of myocar-
dial perfusion scintigraphy in conjunction with exercise
stress testing improves the accuracy for the diagnosis of
CAD. However, many studies have shown that myocardial
perfusion abnormalities may occur in patients with LVH in
the absence of significant coronary angiographic abnor-
malities (8 –10). Exercise echocardiography is increas-
ingly used for the diagnosis and functional evaluation of
CAD. Exercise echocardiography has been shown to
provide incremental data for the identification of
patients who are at a higher risk of cardiac events (11–14).
However, the role of exercise echocardiography in the
prognostic stratification of patients with LVH has not
been evaluated. Additionally, it is not known whether LV
mass has an impact on prognosis independent of the resting
LV function and exercise capacity in patients with LVH.
The aims of this study were: 1) to define the clinical
parameters associated with an increased risk of all-cause
mortality and hard cardiac events in patients with LVH
referred for exercise stress testing; and 2) to determine
whether exercise stress testing and echocardiographic data
are of incremental value in the risk stratification of patients
with LVH.
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METHODS
Patients. The population of this study was selected from
patients referred between 1990 to 1995 for exercise echo-
cardiography for the diagnosis or functional evaluation of
CAD. Patients were included if they had an increased mean
LV wall thickness (11 mm) (15). Exclusion criteria were
left bundle branch block, significant valvular heart disease,
or previous valve surgery. The final population of the study
consisted of 483 patients. The Institutional Review Board
approved the study.
Data regarding patients’ history and risk factors were
entered in our computerized database at the time of the
exercise echocardiogram. Hypercholesterolemia was defined
as total cholesterol 200 mg/dl or use of a cholesterol-
lowering agent. Hypertension was defined as blood pressure
140/90 mm Hg or use of antihypertensive medication.
Diabetes mellitus was defined by the presence of a fasting
blood glucose concentration140 mg/dl or requirement for
insulin or orally administered hypoglycemic agents.
Exercise echocardiography. Patients underwent symptom-
limited treadmill exercise testing according to the Bruce
protocol in 83%, Naughton protocol in 10%, and modified
Bruce protocol in 7%. Standard blood pressure and 12-
channel ECG monitoring were performed. Two-
dimensional echocardiographic images were obtained from
the parasternal and apical windows at rest and immediately
after exercise. Left ventricular septal thickness, posterior
wall thickness, and chamber size were measured at rest in
the parasternal long-axis view at end diastole. Mean wall
thickness was defined as the average of septal and posterior
wall thicknesses. Left ventricular mass was calculated using
Troy’s method, and measurements were made in accordance
with the American Society of Echocardiography criteria
(16) as follows: LV mass (g)  1.04 [(IVS  LVDD 
PWT)3  (LVDD)3] , where IVS is interventricular septal
thickness in cm, LVDD is left ventricular diastolic diame-
ter, and PWT is left ventricular posterior wall thickness in
cm. The result was then corrected by the following equation
(17) to correlate with necropsy mass: LV mass (g)  0.8
(LV mass)  0.6 . The LV mass was indexed by body
surface area using normal limits from the Framingham
Heart study. Left ventricular mass index116 g/m2 in men
and 104 g/m2 in women was considered abnormal (18).
Patients who had normal LV mass index were considered to
have concentric remodeling (19).
Interpretation of images. Both digitized and videotape-
recorded images were used for interpretation of the studies
(20). Ejection fraction (EF) at rest was measured using a
previously validated (21) modification of the method of
Quinones et al. (22) or by visual estimation (23) and at
exercise by visual estimation. Regional wall motion was
assessed semiquantitatively by an experienced echocardiog-
rapher blinded to clinical information. Wall motion at rest
and with exercise was scored 1 through 5 according to a
16-segment model (24). Regional wall motion score index
was determined at rest and peak exercise as the sum of the
segmental scores divided by the number of visualized
segments. This method has been previously validated in our
laboratory (25). The development of new or worsening wall
motion was considered indicative of myocardial ischemia. A
wall motion abnormality present at rest and unchanged with
exercise was classified as fixed. Exercise echocardiography
results were defined as abnormal if there was ischemia or
fixed wall motion abnormalities (11). The exercise ECG
was considered positive for ischemia if there was horizontal
or downsloping ST-segment depression of1 mm at 80 ms
after the J point, nondiagnostic if the baseline ST-segment
was abnormal, or negative for ischemia in the absence of the
criteria described above. Workload was measured in meta-
bolic equivalents (METs).
Intraobserver and volumetric validation. In a sample of
25 tests randomly selected to represent a range of responses,
image qualities, and LV mass index, two independent
observers determined the EF at rest and with exercise. An
independent observer measured EF at rest and with exercise
using the modified biplane Simpson method (Image Vue,
Nova Microsonics, Allendale, New Jersey).
Follow-up. Follow-up was obtained by mailed question-
naires and scripted telephone interviews. Events were veri-
fied by contacting the patients’ primary physician and
reviewing medical records and death certificates. The end
points considered were all-cause mortality and hard cardiac
events defined as nonfatal myocardial infarction (MI) and
cardiac death. Sudden death occurring without another
explanation was included as cardiac death. Coronary revas-
cularization procedures during the follow-up period were
also noted. Patients who had coronary angioplasty or coro-
nary artery bypass surgery before other events were censored
at the time of revascularization in the analysis of hard
cardiac events.
Statistical analysis. Continuous variables were reported as
mean  SD, and categorical variables as percentages. The
level of agreement (interobserver and intermethod) for
exercise EF was assessed by the method of Bland and
Altman. Cohen’s kappa statistic was used to assess the level
of agreement for the subjective categorization of the EF
response to exercise (increased vs. unchanged or decreased)
and the intermethod categorization of the EF response.
Univariable and multivariable association of clinical and
exercise echocardiographic variables with the end points
were assessed in the Cox proportional hazards framework.
Abbreviations and Acronyms
CAD  coronary artery disease
ECG  electrocardiogram/electrocardiographic
EF  ejection fraction
LV  left ventricle/ventricular
LVH  left ventricular hypertrophy
METs  metabolic equivalents
MI  myocardial infarction
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The results of these analyses were summarized as hazard
ratios with corresponding 95% confidence intervals. The
incremental value of exercise stress and echocardiographic
information over clinical data for the prediction of points of
interest was assessed in four modeling steps. The first step
consisted of fitting a multivariable model of only clinical
data. Exercise ECG and hemodynamic variables were added
in a stepwise forward selection manner to the clinical model.
Rest echocardiographic variables were then added to this
model in a stepwise forward selection manner. In the final
step, exercise echocardiographic variables were added.
RESULTS
Clinical data. The mean age was 66  11 years. There
were 281 men. Risk factors for CAD were hypertension in
443 patients (92%), diabetes mellitus in 81 patients (17%),
hypercholesterolemia in 266 patients (55%), and smoking in
255 patients (53%). Sixty-seven patients (14%) had a
previous MI, and 70 (14%) underwent previous myocardial
revascularization. Typical anginal pectoris was present in
106 patients (22%), and 166 patients (34%) had atypical
chest pain. Left ventricular hypertrophy on baseline ECG
was present in 101 patients (21%). Medications included
beta-blockers in 116 patients (24%) and calcium channel
blockers in 183 patients (38%).
Exercise stress test. A significant increase in heart rate (74
 14 beats/min vs. 135  25 beats/min, p  0.0001) and
systolic blood pressure (146 22 mm Hg vs. 186 34 mm
Hg, p  0.0001) occurred during exercise. The mean
workload was 7.5  2.9 METs, and 288 patients (60%)
achieved 85% of the age-predicted maximum heart rate.
Exercise-induced angina occurred in 51 patients (11%), and
the ECG was positive for ischemia in 93 patients (19%).
Echocardiographic data. Resting wall motion abnormali-
ties were present in 163 patients (34%). The LV mass index
was increased in 354 patients (73%), and 129 patients (27%)
had concentric remodeling. The mean LV mass index was
139 40 gm/m2. Ejection fraction was 60 8% at rest and
66  11% after exercise (p  0.001). Exercise-induced wall
motion abnormalities (regional ischemia) occurred in 169
patients (35%). Of these, 96 patients also had resting wall
motion abnormalities. The exercise echocardiogram was
considered normal in 247 patients (51%).
Interobserver and intermethod variation. There was
100% interobserver agreement (kappa  1.0) for the sub-
jective categorization of the EF response to exercise. Two
observers, one using volumetrics and the other visual assess-
ment, agreed on the EF response to exercise in 96% of the
cases (kappa 0.78 0.14). The interobserver difference in
the subjective assessment of exercise EF was 0.4  7 (95%
limits of agreement 3%, 3%). The mean difference be-
tween the visually estimated exercise EF and volumetric
assessment was 0.2  1.0 (95% limits of agreement 4%,
3%).
Outcome. During a median follow-up of 3 years (range, 1
day to 7.6 years), 46 patients died. Death was due to cardiac
causes in 20 patients; malignancies in 11 patients; stroke in
5 patients; renal failure in 5 patients; infection in 2 patients;
and chronic obstructive pulmonary disease, suicide, and
trauma each occurring in 1 patient. Fourteen patients had
nonfatal MI. A total of 33 hard cardiac events were noted.
An additional patient with cardiac death was not included as
he underwent myocardial revascularization after the test.
The cumulative mortality rate was higher in patients with
abnormal, compared with patients with normal, exercise
echocardiography (3% vs. 0.4% at one year, 11.7% vs. 3.7%
at three years, and 18.3% vs. 9.5% at five years, p  0.02).
The cumulative hard cardiac event rate was higher in
patients with abnormal, compared with patients with nor-
mal, exercise echocardiography (3.4% vs. 0.8% at one year,
8.6% vs. 3.8% at three years, and 15.8% vs. 6.9% at five
years, p  0.02).
Clinical, ECG, and hemodynamic variables associated
with the risk of mortality and hard cardiac events in the
univariate analysis are listed in Table 1. Predictors of events
in the in the incremental multivariate analysis models are
presented in Tables 2 (all-cause mortality) and 3 (hard
cardiac events).
Revascularization procedures. During the follow-up pe-
riod, 60 patients (12%) underwent coronary revasculariza-
tion. In 21 patients, revascularization was performed within
3 months after the exercise stress test. Patients who under-
went revascularization had a higher prevalence of abnormal
exercise echocardiogram (73% vs. 45%, p  0.0001) and
new or worsening wall motion abnormalities (63% vs. 31%,
p  0.0001), and more frequently had exercise-induced
ST-segment depression (40% vs. 16%, p  0.0001).
DISCUSSION
In this study we evaluated the role of clinical, exercise stress,
and echocardiographic data in the prediction of mortality
and nonfatal MI in 483 patients with LVH and suspected or
known CAD. During a median follow-up of 3 years, events
occurred in 60 patients and included 46 deaths, 20 of which
were due to cardiac causes, and 14 nonfatal MIs. Indepen-
dent predictors of outcome were studied by an incremental
multivariate analysis model that took into consideration the
clinical data and the sequence of noninvasive studies (exer-
cise stress test, resting echocardiogram, and exercise echo-
cardiogram), which the physician may order to improve risk
stratification.
Among clinical parameters, a history of coronary artery
bypass grafting was independently associated with increased
risk hard cardiac events. Age, gender, and other risk factors
were not predictive of outcome. This demonstrates the
difficulties that confront the physician who attempts to
risk-stratify patients with LVH using clinical predictors
alone. Perhaps the risk associated with LVH was high
enough to account for the lack of additional impact of other
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risk factors on the outcome. A lower exercise heart rate
blood pressure product was incremental to clinical parame-
ters in the prediction of mortality and hard cardiac events.
These findings are consistent with the known association of
impairment of heart rate and systolic blood pressure re-
sponse to exercise with increased risk of cardiac events in the
general population (4,5). Additionally, the workload pre-
sented in METs was predictive of overall mortality. Exercise
stress ECG data were not predictive of outcome, which may
be explained by the low accuracy of ECG changes for the
detection of CAD in patients with LVH.
In the next step of the incremental multivariate analysis,
resting echocardiographic data were added. Left ventricular
mass index was incremental to clinical and exercise stress
testing data in the prediction of all-cause mortality, inde-
pendent of exercise capacity and resting LV function. These
findings may be explained by the possibility that patients
with a larger LV mass index had more severe target-organ
damage with a higher probability of dying of cardiac causes,
strokes, and renal failure. The severity of resting LV
dysfunction (presented as wall motion score index) was
incremental to clinical and exercise stress testing data in the
prediction of hard cardiac events. The presence of more
severe resting LV dysfunction is an established risk for death
from subsequent heart failure or fatal arrhythmias. Further-
more, extensive wall motion abnormalities are a marker of
extensive CAD with the associated high risk of cardiac
death and nonfatal MI. This may explain the association
between a higher wall motion score index and the risk of
hard cardiac events in this study.
In the final step, exercise echocardiographic data were
added. Failure to increase EF with exercise was predictive of
mortality and hard cardiac events, and was incremental to
clinical data, exercise hemodynamics, resting LV function,
and LV mass index. Presence of exercise-induced wall
motion abnormalities was not predictive of outcome. Subtle
changes of global function may be more appreciable than
subtle changes of regional function. Poor EF response to
Table 2. Independent Predictors of All-Cause Mortality Using Four-Step Model
Models Parameters
Hazard
Ratio
(95% CI)* p Value
Model
Chi-Square‡
Clinical Age† 1.0 (0.7–1.5) 0.95 12
Male gender 1.5 (0.8–2.9) 0.2
Known CAD 1.3 (0.7–2.4) 0.38
Clinical  exercise stress METs† 0.5 (0.3–0.9) 0.01 37
Rate pressure product† 0.7 (0.5–0.9) 0.003
Clinical, exercise stress 
rest echocardiography
Left ventricular mass
index†
1.4 (1.1–1.9) 0.007 45
Clinical, exercise stress, rest
echocardiography 
exercise echocardiography
Failure to increase ejection
fraction
2.1 (1.1–3.8) 0.02 51
*Information is based on final model fit; †Hazard ratio and 95% CI per 1 SD change in covariate; ‡Degrees of freedom for testing
improvement in model fit over previous model is equal to the number of variables presented within modeling increments.
CAD  coronary artery disease; CI  confidence interval; METs  metabolic equivalents.
Table 1. Univariate Association of Clinical, Exercise Stress Test, and Echocardiographic
Variables With Risk of Hard Cardiac Events and All-Cause Mortality
Clinical/Exercise Parameters
Hard Cardiac Events All-Cause Mortality
Chi-Square
Hazard Ratio
(CI) Chi-Square
Hazard Ratio
(CI)
History of CAD 10.2 3.06 (1.54–6.08) 8.2 2.3 (1.3–4.2)
History of angina 6.8 2.6 (1.27–5.3) 3.3 1.8 (0.96–3.3)
85% of predicted HR achieved 13.3 0.25 (0.12–0.53) 16.6 0.27 (0.14–0.51)
*Exercise HR 18.8 0.74 (0.66–0.82) 26.6 0.74 (0.66–0.82)
†Exercise rate pressure product 21.5 0.16 (0.07–0.35) 28.5 0.16 (0.08–0.3)
*Left ventricular mass index 4.5 1.08 (1.01–1.16) 5.1 1.07 (1.01–1.14)
*Rest EF 14 0.54 (0.35–0.74) 8.2 0.66 (0.48–0.9)
*Exercise EF 31.1 0.54 (0.48–0.66) 25.3 0.60 (0.54–0.74)
Failure to increase EF 22.6 0.19 (0.1–0.38) 20 0.27 (0.15–0.48)
Exercise WMA 5.4 2.35 (1.14–4.86) 5.6 2.1 (1.1–3.9)
New WMA (ischemia) 3.6 1.9 (0.97–3.84) 3.3 1.7 (0.96–3.1)
‡% of ischemic segments 7.2 1.85 (1.18–2.88) 11.5 1.7 (1.25–2.3)
§Rest WMSI 17.4 5.6 (2.5–12.7) 13.4 4 (1.9–8.5)
§Exercise WMSI 19 4.7 (2.35–9.5) 19.4 3.6 (2–6.4)
*Per 10 U increment; †Per 1,000 U increment; ‡Per 25% increment (4 of 16 segments); §Per 1 U change.
CAD  coronary artery disease; CI  confidence interval; EF  ejection fraction; HR  heart rate; WMA  wall motion
abnormalities; WMSI  wall motion score index.
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exercise may reflect more extensive disease and, conse-
quently, a more adverse prognosis than regional abnormal-
ities alone. Furthermore, a poor EF response to exercise may
indicate diffuse microvascular abnormalities in patients with
LVH (26,27). Impaired EF response to exercise was previ-
ously demonstrated as a marker of adverse prognosis,
although the specificity for the diagnosis of CAD was low
(28,29).
Event rate in patients with normal exercise echocardio-
gram. Patients with a normal exercise echocardiogram in
this study had a significantly lower mortality rate (0.4% vs.
3% at one year, 3.7% vs. 11.7% at three years, and 9.5% vs.
18% at five years) and hard cardiac event rate (0.8% vs. 3.4%
at one year, 3.8% vs. 8.6% at three years, and 6.9% vs. 15.8%
at five years, p  0.001) as compared with patients with an
abnormal exercise echocardiogram. However, the relatively
low risk status of patients with a normal exercise echocar-
diogram was maintained only to three years. A follow-up
study after three years may be useful to reassess the risk
status of these patients; further studies are required to
establish this as a recommendation.
Myocardial ischemia. Myocardial ischemia (new or wors-
ened wall motion abnormalities) was univariately associated
with increased risk of cardiac events. However, the relative
risk was marginal when compared with the risk associated
with the presence and extent of resting wall motion abnor-
malities. This may be explained by the possibility that some
of the resting wall motion abnormalities represent myocar-
dial ischemia rather than infarction. This contention is
supported by the fact that 34% of patients in this study had
resting wall motion abnormality, although a history of
previous MI was obtained in only 14%. Some of these wall
motion abnormalities may be the consequence of hyperten-
sive heart disease or the advanced phase of remodeling of a
hypertrophied ventricle and may occur in the absence of
significant CAD. Finally, revascularization procedures were
more frequently performed in patients with ischemia. Al-
though the results of the test may be a source of bias in
referral to revascularization, it is possible that prognosis has
been improved in some of these patients by revasculariza-
tion, thus limiting the value of ischemia in predicting hard
cardiac events.
Previous studies. To our knowledge, the prognostic value
of stress echocardiography in patients with LVH has not
been previously studied. Recent studies have demonstrated
that the specificity of stress echocardiography for the diag-
nosis of CAD is maintained in patients with LVH (15,30).
Few studies have established a comparison between various
stress testing modalities for the diagnosis of CAD using
angiography as gold standard in patients with LVH. These
studies reported controversial results with some indicating a
similar accuracy between both techniques (30) and others
indicating a higher specificity of stress echocardiography
(10). It is noteworthy that the presence of myocardial
perfusion and wall motion abnormalities in the absence of
significant CAD may represent a disease beyond angio-
graphic detection, with independent prognostic implica-
tions. A recent study utilizing dual isotope myocardial
perfusion single photon emission computed tomography in
patients with ECG evidence of LVH demonstrated that the
summed stress score of perfusion abnormalities added in-
cremental prognostic information after adjusting for clinical
parameters. The impact of LV mass on prognosis was not
evaluated in that study (31).
Levy et al. (18) reported risk of event in terms of each
increment of 50 gm/m of LV mass, consistent with the
results of this study. Our study showed additionally that this
risk is incremental to resting LV function, hemodynamic
response to exercise, and functional capacity. Previous stud-
ies have demonstrated that patients with concentric LV
hypertrophy have the highest event rate as compared with
other patterns of LVH (19,32–34). In our study cardiac
events occurred less frequently in patients with concentric
remodeling. However, the pattern of hypertrophy was not
an independent predictor of outcome when LV mass index
was considered as a continuous variable.
Study limitations. A limitation of the study is that 24% of
patients were receiving beta-blocker therapy at the time of
the exercise stress test, which may have resulted in under-
estimation of the role of ischemia by ECG and/or echocar-
Table 3. Independent Predictors of Hard Cardiac Events Using Four-Step Model
Models Parameters
Hazard
Ratio
(95% CI)*
p
Value
Model
Chi-Square‡
Clinical Age† 1.0 (0.7–1.5) 0.97 16
Male gender 1.5 (0.8–2.9) 0.79
Previous CABG 2.6 (1.2–5.4) 0.01
Clinical  exercise stress Rate pressure product† 0.6 (0.5–0.8) 0.0009 29
Clinical, exercise stress 
rest echocardiography
Resting wall motion score
index†
1.4 (1.1–1.8) 0.008 37
Clinical, exercise stress, rest
echocardiography 
exercise echocardiography
Failure to increase ejection
fraction†
3.3 (1.6–6.9) 0.001 47
*Information is based on final model fit; †Hazard ratio and 95% CI per 1 SD change in covariate; ‡Degrees of freedom for testing
improvement in model fit over previous model is equal to the number of variables presented within modeling increments.
CABG  coronary artery bypass grafting; CI  confidence interval.
133JACC Vol. 41, No. 1, 2003 Elhendy et al.
January 1, 2003:129–35 Risk Stratification in Patients With LVH
diography in the prediction of outcome. Assessment of EF
in this study was performed by subjective visual analysis.
However, the current echocardiographic methods used for
quantitative assessment of EF have limitations because these
assume a geometric model. Nevertheless, we found a good
agreement between visual and volumetric assessment in a
randomly selected subset of patients in this study. The use
of visual estimation of EF in stress echocardiographic
studies has previously been validated by our group (21) as
well as by other investigators (35). Finally, the number of
cardiac events in this study was relatively low, which may
explain the lack of independent association of LV mass
index with these events. The low event rate may reflect a
lower risk status in a population able to perform an exercise
stress test and, possibly, improved outcome with medical
treatment. Further studies are needed to assess predictors of
events during longer-term follow-up.
Conclusions. It is concluded that LV mass index and EF
response to exercise are independent predictors of mortality
in patients with LVH. The associated risk is incremental to
clinical data, exercise capacity, hemodynamic response to
exercise, and resting LV function. A normal exercise echo-
cardiogram predicts a relatively low mortality and cardiac
event rate during the subsequent three years.
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